CTSS and Alzheimer disease: Studies showed that disrupting lysosomal proteolysis by inhibiting cathepsins or suppressing lysosomal acidification slowed axonal transport and caused selective accumulation within dystrophic neurites, a key feature of AD [218,219,220].